2 vials x ml GcMAF (1500 ng/ ml) 8 doses -- please contact us for pricing
4 vials x ml GcMAF (1500 ng/ ml) 16 doses -- please contact us for pricing
6 vials x ml GcMAF (1500 ng/ ml) 24 doses -- please contact us for pricing
Suggested doses :
Large joints: 2 to 4 mg
Small joints: to 1 mg
Bursae: 2 to 4 mg
Tendon Sheaths: to 1 mg
Injections may be repeated from once every 3 to 5 days to once every 2 to 3 weeks
-Dose will vary according to the degree of inflammation and the size and location of the affected site.
-Intrasynovial and soft tissue injections should be limited to 1 or 2 sites; frequent intra-articular injections may cause damage to joint tissue.
Use: As adjunctive therapy for an acute episode or exacerbation of synovitis of osteoarthritis, rheumatoid arthritis, acute and subacute bursitis, acute gouty arthritis, epicondylitis, acute nonspecific tenosynovitis, and posttraumatic osteoarthritis.
Transdermal patches (adhesive patches placed on the skin) may also be used to deliver a steady dose through the skin and into the bloodstream. Testosterone-containing creams and gels that are applied daily to the skin are also available, but absorption is inefficient (roughly 10%, varying between individuals) and these treatments tend to be more expensive. Individuals who are especially physically active and/or bathe often may not be good candidates, since the medication can be washed off and may take up to six hours to be fully absorbed. There is also the risk that an intimate partner or child may come in contact with the application site and inadvertently dose himself or herself; children and women are highly sensitive to testosterone and can suffer unintended masculinization and health effects, even from small doses. Injection is the most common method used by individuals administering AAS for non-medical purposes.